Cathleen Flahardy

November 06, 2012 | Inside Counsel

Last week, automakers Hyundai and Kia admitted to overstating the estimated fuel economy on some of their cars. And this week, consumers have responded.

By Cathleen Flahardy

4 minute read

November 05, 2012 | Inside Counsel

According to the October jobs report, legal services jobs are upbut barely.

By Cathleen Flahardy

2 minute read

November 02, 2012 | Inside Counsel

Rhode Island filed suit yesterday against a former Boston Red Sox pitcher, claiming he and others committed fraud and engaged in racketeering and conspiracy by misleading the state into approving a $75 million loan guarantee for a video game company.

By Cathleen Flahardy

2 minute read

November 01, 2012 | Inside Counsel

Under fire for possibly violating the Foreign Corrupt Practices Act (FCPA), Wal-Mart Stores Inc. has created the new position of international compliance chief in an effort to prevent future problems.

By Cathleen Flahardy

2 minute read

October 31, 2012 | Inside Counsel

The Allied Pilots Association (APA)the union that represents pilots for AMR Corp.s American Airlines (AA)announced yesterday that the two parties may be close to an agreement.

By Cathleen Flahardy

5 minute read

October 30, 2012 | Inside Counsel

There are a couple of lawyers that may be very busy come Nov. 7.

By Cathleen Flahardy

5 minute read

October 29, 2012 | Corporate Counsel

Planning a vacation is an apt analogy for a company venturing into China

By Cathleen Flahardy

2 minute read

October 29, 2012 | Corporate Counsel

This GC knew he wanted a life and business, and law was the perfect gateway

By Cathleen Flahardy

13 minute read

October 29, 2012 | Inside Counsel

A former deputy attorney general under former President George H.W. Bush will be joining law firm Morgan, Lewis & Bockius.

By Cathleen Flahardy

2 minute read

October 26, 2012 | Inside Counsel

Germany-based pharmaceutical maker Boehringer Ingelheim Pharmaceuticals has settled a suit against it brought by the U.S. Department of Justice, which accused the company of marketing some of its drugs for unapproved uses.

By Cathleen Flahardy

5 minute read